About: MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.57 (+2.11%)
MLTX NASDAQ MoonLake Immunotherapeutics
MoonLake Immunotherapeutics share price
Atividade de preço de MLTX
Último preço
$ 12,570
Variação (24h)
0,26 USD (2,11%)
Volume
4.09M
Volume (média 4 sem.)
-
Abertura
$ 12,36
Variação do dia
$ 12,31 - $ 12,95
Fechamento anterior
$ 12,31
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
MLTX price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals